TUCSON,
Ariz., March 15, 2023 /PRNewswire/ -- Accelerate
Diagnostics, Inc. (NASDAQ: AXDX) announced today that management
will host a conference call on Wednesday,
March 29, 2023, at 4:30 p.m. Eastern
Time to review 2022 fourth quarter and full year
results.
To listen to the audio webcast online, visit ir.axdx.com. A
replay of the audio webcast will be available for 30 days.
To listen by phone, dial +1.877.883.0383 and enter the Elite
Entry Number: 6648486. International participants may dial
+1.412.902.6506. Please dial in 10-15 minutes prior to the start of
the conference.
A replay of the call will be available by telephone at
+1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the
replay code 2450672 until April 19, 2023.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics
company dedicated to providing solutions for the global challenges
of antibiotic resistance and sepsis. The Accelerate Pheno® system
and Accelerate PhenoTest® BC kit combine several
technologies aimed at reducing the time clinicians must wait to
determine the most optimal antibiotic therapy for deadly
infections. The FDA cleared system and kit fully automate the
sample preparation steps to report phenotypic antibiotic
susceptibility results in approximately 7 hours direct from
positive blood cultures. Recent external studies indicate the
solution offers results 1-2 days faster than existing methods,
enabling clinicians to optimize antibiotic selection and dosage
specific to the individual patient days earlier.
"Accelerate Diagnostics" and diamond shaped logos and marks are
registered trademarks of Accelerate Diagnostics, Inc.
For more information about the company, its products and
technology, or recent publications, visit axdx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2022-fourth-quarter-and-full-year-results-301772263.html
SOURCE Accelerate Diagnostics, Inc.